Successful management of peritoneal dialysis catheter-related infection caused by Mycobacterium abscessus subsp. massiliense with catheter replacement in a pediatric patient
This case report describes the successful management of a peritoneal dialysis catheter-related infection caused by *Mycobacterium abscessus* subsp. *massiliense* in a 14-year-old girl through early catheter exchange combined with prolonged macrolide-based multidrug therapy, ultimately allowing the patient to maintain dialysis until a successful kidney transplantation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The Invisible Invader and the Body's Plumbing
Imagine your body as a bustling city with a sophisticated plumbing system designed to filter out waste. For some people whose kidneys have stopped working, doctors install a special "external filter" called peritoneal dialysis (PD). This involves threading a soft tube, or catheter, through the belly wall into the abdominal cavity. The body's natural lining acts as a filter, cleaning the blood as fluid flows in and out. However, just like any open door to a city, this tube is a potential entry point for trouble. Sometimes, tiny, stubborn invaders—bacteria that don't show up on standard tests—can sneak in and set up camp around the tube, causing pain, pus, and swelling. These are called nontuberculous mycobacteria (NTM). They are like the "ghosts" of the bacterial world: hard to catch, hard to kill, and they love to hide in the deep tunnels under the skin. Doctors have long known these infections are tricky, but they often treat them like a generic problem, using a "one-size-fits-all" approach. The big question is: if we can identify the exact species of these invisible invaders, can we use a smarter, more targeted strategy to save the patient's plumbing and keep them out of the hospital?
The Case of the 14-Year-Old Detective Story
This paper tells the story of a 14-year-old girl with a rare condition called Sensenbrenner syndrome who needed a kidney filter. Eight months after her dialysis tube was installed, her belly button area started hurting and oozing pus. At first, the doctors were stumped. They swabbed the wound, but the standard lab tests came back negative—no bacteria found. It was like looking for a thief in a dark room with a flashlight that couldn't see the shadows. The girl was given a common antibiotic, and while the pain went away, the pus kept coming.
The medical team decided to play detective and keep looking. They took more samples, and this time, they found the culprit: acid-fast bacilli. Using a high-tech tool called a mass spectrometer (think of it as a super-accurate fingerprint scanner for bugs), they identified the invader as a member of the Mycobacterium abscessus family. But the story didn't stop there. The team dug deeper and used a genetic test to find the specific "subspecies": M. abscessus subsp. massiliense. This distinction is crucial because, much like how different breeds of dogs need different training, different subspecies of this bacteria react differently to medicine.
The treatment plan was a three-pronged attack. The girl was admitted to the hospital and started on a powerful mix of three antibiotics: intravenous imipenem, oral linezolid, and an oral macrolide. On the fourth day, the doctors performed a delicate surgery: they removed the infected tube and immediately put in a brand-new one. This was a risky move, like swapping a broken pipe while the water is still running, but it was necessary. Inside the tunnel where the old tube had lived, they found a pocket of pus, confirming the infection had burrowed deep.
The battle wasn't over. The pus kept coming from the old exit spot, so the team added a fourth drug, amikacin. However, this drug had a side effect: it was hurting the girl's hearing. So, they had to stop it. They also had to stop the linezolid because it was lowering her blood cell counts. The team adjusted the plan, keeping the imipenem and the macrolide, and later swapped some drugs for others (faropenem and sitafloxacin) based on how the bacteria reacted to them in the lab. After 103 days in the hospital, she went home.
Six months later, the bacteria showed up again in a test, but this time, there was no abscess or swelling on the MRI scan. The team kept the antibiotics going, and eventually, the tests came back clean. The girl's belly lining eventually got too scarred to use for dialysis, so she switched to a different type of dialysis and then received a kidney transplant. Once the new kidney was working, all the antibiotics were stopped. A full year later, the infection had not returned.
What This Means for the Future
This case suggests that when a dialysis tube infection won't go away, doctors shouldn't just guess. They should keep testing until they find the exact type of bacteria. Identifying the specific subspecies, like M. abscessus subsp. massiliense, helps doctors choose the right weapons. In this girl's case, catching the specific bug early allowed them to use a targeted mix of drugs and swap the tube quickly, which saved her dialysis treatment for a while. The paper suggests that for this specific type of bacteria, a combination of early tube replacement and long-term, multi-drug therapy might be a winning strategy. However, the authors are careful to note that this is just one story. They can't say for sure that this will work for everyone yet, and they need more cases to be certain. But for now, it's a hopeful sign that with better detective work, even the sneakiest bacterial invaders can be outsmarted.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.